621 related articles for article (PubMed ID: 16705124)
21. Prospective analysis of association between statin use and breast cancer risk in the women's health initiative.
Desai P; Chlebowski R; Cauley JA; Manson JE; Wu C; Martin LW; Jay A; Bock C; Cote M; Petrucelli N; Rosenberg CA; Peters U; Agalliu I; Budrys N; Abdul-Hussein M; Lane D; Luo J; Park HL; Thomas F; Wactawski-Wende J; Simon MS
Cancer Epidemiol Biomarkers Prev; 2013 Oct; 22(10):1868-76. PubMed ID: 23975947
[TBL] [Abstract][Full Text] [Related]
22. Statin use and the risk of incident dementia: the Cardiovascular Health Study.
Rea TD; Breitner JC; Psaty BM; Fitzpatrick AL; Lopez OL; Newman AB; Hazzard WR; Zandi PP; Burke GL; Lyketsos CG; Bernick C; Kuller LH
Arch Neurol; 2005 Jul; 62(7):1047-51. PubMed ID: 16009757
[TBL] [Abstract][Full Text] [Related]
23. HMG-CoA reductase inhibitors and the risk of vertebral fracture.
Schoofs MW; Sturkenboom MC; van der Klift M; Hofman A; Pols HA; Stricker BH
J Bone Miner Res; 2004 Sep; 19(9):1525-30. PubMed ID: 15312254
[TBL] [Abstract][Full Text] [Related]
24. Use of oral conjugated estrogen alone and risk of breast cancer.
Zhang SM; Manson JE; Rexrode KM; Cook NR; Buring JE; Lee IM
Am J Epidemiol; 2007 Mar; 165(5):524-9. PubMed ID: 17132697
[TBL] [Abstract][Full Text] [Related]
25. Statin use and breast cancer risk in a large population-based setting.
Boudreau DM; Yu O; Miglioretti DL; Buist DS; Heckbert SR; Daling JR
Cancer Epidemiol Biomarkers Prev; 2007 Mar; 16(3):416-21. PubMed ID: 17372235
[TBL] [Abstract][Full Text] [Related]
26. Prospective study of leukocyte count as a predictor of incident breast, colorectal, endometrial, and lung cancer and mortality in postmenopausal women.
Margolis KL; Rodabough RJ; Thomson CA; Lopez AM; McTiernan A;
Arch Intern Med; 2007 Sep; 167(17):1837-44. PubMed ID: 17893304
[TBL] [Abstract][Full Text] [Related]
27. Cholesterol-lowering drugs and advanced prostate cancer incidence in a large U.S. cohort.
Jacobs EJ; Rodriguez C; Bain EB; Wang Y; Thun MJ; Calle EE
Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2213-7. PubMed ID: 17971518
[TBL] [Abstract][Full Text] [Related]
28. Effect of statins combined with estradiol on the proliferation of human receptor-positive and receptor-negative breast cancer cells.
Mueck AO; Seeger H; Wallwiener D
Menopause; 2003; 10(4):332-6. PubMed ID: 12851516
[TBL] [Abstract][Full Text] [Related]
29. Comparison of incidences of cardiovascular events among new users of different statins: a retrospective observational cohort study.
Heintjes EM; Penning-van Beest FJ; Johansson S; Stalenhoef AF; Herings RM
Curr Med Res Opin; 2009 Nov; 25(11):2621-9. PubMed ID: 19743959
[TBL] [Abstract][Full Text] [Related]
30. Alcohol consumption and breast cancer risk in the Women's Health Study.
Zhang SM; Lee IM; Manson JE; Cook NR; Willett WC; Buring JE
Am J Epidemiol; 2007 Mar; 165(6):667-76. PubMed ID: 17204515
[TBL] [Abstract][Full Text] [Related]
31. The influence of statin medications on prostate-specific antigen levels.
Hamilton RJ; Goldberg KC; Platz EA; Freedland SJ
J Natl Cancer Inst; 2008 Nov; 100(21):1511-8. PubMed ID: 18957682
[TBL] [Abstract][Full Text] [Related]
32. Recreational physical activity and risk of postmenopausal breast cancer based on hormone receptor status.
Bardia A; Hartmann LC; Vachon CM; Vierkant RA; Wang AH; Olson JE; Sellers TA; Cerhan JR
Arch Intern Med; 2006 Dec 11-25; 166(22):2478-83. PubMed ID: 17159013
[TBL] [Abstract][Full Text] [Related]
33. Incident invasive breast cancer, geographic location of residence, and reported average time spent outside.
Millen AE; Pettinger M; Freudenheim JL; Langer RD; Rosenberg CA; Mossavar-Rahmani Y; Duffy CM; Lane DS; McTiernan A; Kuller LH; Lopez AM; Wactawski-Wende J
Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):495-507. PubMed ID: 19190147
[TBL] [Abstract][Full Text] [Related]
34. Physical activity in different periods of life and the risk of breast cancer: the Norwegian-Swedish Women's Lifestyle and Health cohort study.
Margolis KL; Mucci L; Braaten T; Kumle M; Trolle Lagerros Y; Adami HO; Lund E; Weiderpass E
Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):27-32. PubMed ID: 15668472
[TBL] [Abstract][Full Text] [Related]
35. Statin and statin-fibrate use was significantly associated with increased myositis risk in a managed care population.
McClure DL; Valuck RJ; Glanz M; Murphy JR; Hokanson JE
J Clin Epidemiol; 2007 Aug; 60(8):812-8. PubMed ID: 17606177
[TBL] [Abstract][Full Text] [Related]
36. Cardiovascular outcomes among patients newly initiating atorvastatin or simvastatin therapy: a large database analysis of managed care plans in the United States.
Foody JM; Joyce AT; Rudolph AE; Liu LZ; Benner JS
Clin Ther; 2008 Jan; 30(1):195-205. PubMed ID: 18343257
[TBL] [Abstract][Full Text] [Related]
37. Influence of estrogen plus testosterone supplementation on breast cancer.
Ness RB; Albano JD; McTiernan A; Cauley JA
Arch Intern Med; 2009 Jan; 169(1):41-6. PubMed ID: 19139322
[TBL] [Abstract][Full Text] [Related]
38. Long-term use of statins and risk of colorectal cancer: a population-based study.
Singh H; Mahmud SM; Turner D; Xue L; Demers AA; Bernstein CN
Am J Gastroenterol; 2009 Dec; 104(12):3015-23. PubMed ID: 19809413
[TBL] [Abstract][Full Text] [Related]
39. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.
Eliassen AH; Missmer SA; Tworoger SS; Spiegelman D; Barbieri RL; Dowsett M; Hankinson SE
J Natl Cancer Inst; 2006 Oct; 98(19):1406-15. PubMed ID: 17018787
[TBL] [Abstract][Full Text] [Related]
40. Long-term use of cholesterol-lowering drugs and cancer incidence in a large United States cohort.
Jacobs EJ; Newton CC; Thun MJ; Gapstur SM
Cancer Res; 2011 Mar; 71(5):1763-71. PubMed ID: 21343395
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
